An insulin analogue that embodies two distinct structural modifications, each of which independently increases insulin activity, has been synthesized and evaluated for biological activity. The analogue, des-(B26-B30)-[AspB10,TyrB25-NH2]insulin is the most potent insulin analogue yet described; it displays an 11- to 13-fold higher activity than natural insulin. The findings are discussed with regard to the receptor-binding domains of insulin.
No takes yet. Share an insight, caveat, or question.
Schwartz et al. (1989) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: